Autolus Therapeutics (AUTL) Tops Q1 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Autolus Therapeutics (AUTL) Tops Q1 EPS by 4c

Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress

May 4, 2023 7:00 AM EDT

Obe-cel, a potentially transformational treatment for relapsed/refractory (r/r) B-cell Acute Lymphoblastic Leukemia (ALL), on track for next data update at ASCO and EHA, with a Biologics License Application (BLA) submission to the US FDA planned by end of the year Establishing core distribution capabilities required to commercialize a CAR T-cell therapy in the US by selecting Cardinal Health as commercial distribution partnerPurpose-built commercial manufacturing facility on track to commence Good... More